Dr. Albert T. Derivan is a Audubon, Pennsylvania based psychiatrist who is specialized in Child & Adolescent. Active license number of Dr. Albert T. Derivan is MD034282E for Child & Adolescent in Pennsylvania. His current practice location is 23438 Shannondell Dr, Audubon. Patients can reach him at 215-260-1721 or can fax him at 610-382-6813. Dr. Albert T. Derivan is M.D. in Child & Adolescent and his NPI number (Unique professional ID assigned by NPPES) is 1235135294. Dr. Albert T. Derivan has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Dr. Albert T. Derivan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1235135294
NPI Enumeration Date:
23 Jun, 2005
NPI Last Update On:
01 Apr, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Albert T. Derivan are as mentioned below.
License Number
Specialization
State
Status
MD034282E
Child & Adolescent
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Albert T. Derivan 23438 Shannondell Dr, Audubon, Pennsylvania
Zip:
19403-5675
Phone Number:
215-260-1721
Fax Number:
610-382-6813
Patients can reach Dr. Albert T. Derivan at 23438 Shannondell Dr, Audubon, Pennsylvania or can call to book an appointment on 215-260-1721.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.